ABC News
Turn on desktop notifications for breaking stories about interest?
OffOn
Activision, Teradata rise; GoPro, Twist Bioscience fall
Stocks that traded heavily or had substantial price changes: Activision, Teradata rise; GoPro, Twist Bioscience fall
ByThe Associated Press
• 1 min read
Gilead Sciences Inc., up $2.63 to $68.46.
The biotechnology company beat Wall Street s fourth-quarter profit forecasts as sales of its COVID-19 treatment jumped.
Activision Blizzard Inc., up $8.93 to $101.61.
The maker of “Call of Duty” and other video games gave investors a solid profit forecast after beating analysts fourth-quarter financial expectations.
Pinterest Inc. up $4.12 to $81.96.
The digital pinboard and shopping tool reported surprisingly good fourth-quarter profit and revenue.
Jan 02 2021, 2:49 PM
December 31 2020, 3:30 PM
January 02 2021, 2:49 PM
(Bloomberg Opinion) Everyone should know Cathie Wood by now.
(Bloomberg Opinion) Everyone should know Cathie Wood by now.
That s because whatever benefits central bankers bequeathed to shareholders with next-to-zero interest rates and the record $14 trillion global money supply increase in 2020, Wood beat every stock picker by betting on the innovators in DNA development who are rescuing the world from the global pandemic.
Among the 367 U.S.-based mutual funds with 60% of their $5 billion (or more) in American equities, her ARK Genomic Revolution ETF, ARK Innovation ETFÂ and ARK Next Generation Internet ETFÂ are far ahead, reaping bonanzas of 203%, 159% and 157%, respectively.
The best stock picker of 2020 wins with disruptive DNA
Matthew A. Winkler, Bloomberg News
What worked in 2020 likely won t work in 2021: Mike O Rourke VIDEO SIGN OUT
Everyone should know Cathie Wood by now.
That s because whatever benefits central bankers bequeathed to shareholders with next-to-zero interest rates and the record US$14 trillion global money supply increase in 2020, Wood beat every stock picker by betting on the innovators in DNA development who are rescuing the world from the global pandemic.
Among the 367 U.S.-based mutual funds with 60 per cent of their US$5 billion (or more) in American equities, her ARK Genomic Revolution ETF, ARK Innovation ETF and ARK Next Generation Internet ETF are far ahead, reaping bonanzas of 203 per cent, 159 per cent and 157 per cent, respectively.
Five Things for Tuesday, including biotech in the burbs and our energy future bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run?
NEW YORK CITY (dpa-AFX) - As 2020 draws to a close, it s time to take a look at the top performing healthcare stocks that we profiled this year. Of the 53 stocks to which our premium subscribers have been alerted, 18 stocks have posted triple-digit gains.
What are the catalysts driving these stocks? Is there more room to run? Let s walk you through the details.
1. DermTech Inc. (DMTK)
DermTech, a commercial-stage genomics company in dermatology, was trading around $11, when we alerted our premium subscribers to it on January 19, 2020. The stock touched a high of $27.42 in intraday trading yesterday and that represents a gain of 136% from our published price.